Showing results (1-10 of 211) with videos related to
Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2016
Individualized Tamoxifen Dose Escalation: Confirmation of Feasibility, Question of UtilityDaniel L Hertz, James M RaeAdvances in Experimental Medicine and Biology|March 19, 2016
Pharmacogenetic Predictors of ResponseDaniel L Hertz, James M RaePharmacogenomics|March 28, 2017
Germline genetic predictors of aromatase inhibitor concentrations, estrogen suppression and drug efficacy and toxicity in breast cancer patientsDaniel L Hertz, N Lynn Henry, James M RaePhysiological Genomics|December 8, 2017
Attempted replication of SNPs in RANKL and OPG with musculoskeletal adverse events during aromatase inhibitor treatment for breast cancerJacqueline M Dempsey, Jingyue Xi, N Lynn Henry, et al.JAMIA Open|January 22, 2024
Incorporation of emergent symptoms and genetic covariates improves prediction of aromatase inhibitor therapy discontinuationIlia Rattsev, Vered Stearns, Amanda L Blackford, et al.Pharmacogenomics|July 27, 2017
Institutional profile of pharmacogenetics within University of Michigan College of PharmacyDaniel L Hertz, Jasmine A Luzum, Amy L Pasternak, et al.Pharmacogenetics and Genomics|February 15, 2024
Attempted replication of pharmacogenetic association of variants in PPP1R14C and CCDC148 with aromatase inhibitor-induced musculoskeletal symptomsYuqing Liang, Christina L Gersch, Jennifer Lehman, et al.Pharmacogenomics|July 11, 2013
Germline pharmacogenetics of paclitaxel for cancer treatmentDaniel L HertzJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2022
Assessment of the Clinical Utility of Pretreatment DPYD Testing for Patients Receiving Fluoropyrimidine ChemotherapyDaniel L HertzExpert Opinion on Drug Metabolism & Toxicology|January 6, 2021
Exploring pharmacogenetics of paclitaxel- and docetaxel-induced peripheral neuropathy by evaluating the direct pharmacogenetic-pharmacokinetic and pharmacokinetic-neuropathy relationshipsDaniel L HertzPageof 22